查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599296

病毒載體製造市場：按類型、疾病和應用分類 - 2025-2030 年全球預測

Viral Vector Manufacturing Market by Type (Adeno-associated Viral Vectors, Adenoviral Vectors, Lentiviral Vectors), Disease (Cancer, Genetic Disorders, Infectious Diseases), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年病毒載體製造市場價值為10.5億美元，預計到2024年將達到12.5億美元，複合年成長率為19.11%，到2030年將達到35.9億美元。

病毒載體製造在基因治療、疫苗生產和其他新型醫學應用領域中發揮重要作用。這些載體充當將遺傳物質運送到細胞中的遞送載體，這是糾正遺傳缺陷或誘導所需細胞反應的重要過程。對病毒載體的需求源於它們有效轉導多種細胞類型的能力，這使得它們對於開發先進治療方法和疫苗至關重要。應用範圍從解決罕見遺傳疾病到廣泛的疫苗生產，最引人注目的是病毒載體平台在 COVID-19 疫苗開發中的成功。最終用途包括製藥公司、生物技術公司、研究機構和受託製造廠商，它們在利用這些技術方面進行了大量投資。基因療法的核准不斷增加、遺傳疾病和慢性病患病率上升以及對創新治療解決方案的需求不斷增加，推動了病毒載體製造的市場成長。此外，擴大研究合作和增加對生物技術領域的投資正在刺激研究和開發，提供利潤豐厚的機會。然而，市場面臨一些挑戰，例如高製造成本、複雜的監管環境和擴充性問題，阻礙了潛力的充分發揮。創新持續專注於提高載體生產力、降低成本和提高交付效率，研究重點是開發新型載體類型和可擴展的生產技術。市場的本質是激進且快速變化的，需要相關人員的敏捷性和遠見來保持競爭優勢。業務成長的機會在於簡化生產機制和解決定價問題，從而顯著擴大消費者獲得這些突破性治療方法。透過專注於夥伴關係和投資尖端研究，我們還可以加速市場進入和擴張。組織應專注於最佳化流程效率和擴大產能，以解決與成本相關的限制並鞏固其市場地位。

主要市場統計
基準年[2023] 10.5億美元
預測年份 [2024] 12.5億美元
預測年份 [2030] 35.9億美元
複合年成長率（%） 19.11%

市場動態：針對快速發展的病毒載體製造市場所揭示的關鍵市場見解

供需的動態交互作用正在改變病毒載體製造市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 癌症、代謝性疾病和心臟病等疾病的盛行率增加
    • 基因療法開發的成長
    • 基於病毒載體的基因治療的臨床試驗註冊人數增加
  • 市場限制因素
    • 病毒載體儲存期限限制
  • 市場機會
    • 對產量最佳化的濃厚興趣
    • 病毒載體生產的創新
  • 市場挑戰
    • 病毒載體生產的嚴格監管指導

波特的五力：駕馭病毒載體製造市場的策略工具

波特的五力框架是了解病毒載體製造市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解病毒載體製造市場的外部影響

外部宏觀環境因素在塑造病毒載體製造市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解病毒載體製造市場的競爭狀況

對病毒載體製造市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣病毒載體製造市場供應商績效評估

FPNV定位矩陣是評估病毒載體製造市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了病毒載體製造市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對病毒載體製造市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 癌症、代謝性疾病和心臟缺陷等疾病的發生率增加
      • 基因療法開發的成長
      • 病毒載體介導的基因治療臨床試驗的招募人數增加
    • 抑制因素
      • 病毒載體的保存期限有限
    • 機會
      • 專注於收益最佳化
      • 病毒載體生產的創新
    • 任務
      • 病毒載體生產的嚴格監管指導
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章病毒載體製造市場：依類型

  • 腺結合病毒載體
  • 腺病毒載體
  • 慢病毒載體
  • 逆轉錄病毒載體

第7章病毒載體製造市場：依疾病分類

  • 癌症
  • 遺傳疾病
  • 感染疾病

第8章病毒載體製造市場：依應用分類

  • 基因治療
  • 疫苗學

第9章美洲病毒載體製造市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區病毒載體製造市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的病毒載體製造市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • ABL Inc.
  • Beckman Coulter, Inc.
  • Biovian Oy
  • Charles River Laboratories International, Inc.
  • Cytiva
  • Finvector
  • FUJIFILM Diosynth Biotechnologies USA, Inc.
  • Genezen Laboratories, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Novartis AG
  • Sanofi SA
  • Spark Therapeutics, Inc. by F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • uniQure NV
Product Code: MRR-FD3F12D54086

The Viral Vector Manufacturing Market was valued at USD 1.05 billion in 2023, expected to reach USD 1.25 billion in 2024, and is projected to grow at a CAGR of 19.11%, to USD 3.59 billion by 2030.

Viral vector manufacturing plays a crucial role in the field of gene therapy, vaccine production, and other novel medical applications. These vectors serve as delivery vehicles to transport genetic material into cells, a process critical for correcting genetic disorders or instigating a desired cellular response. The necessity of viral vectors stems from their ability to effectively transduce a broad spectrum of cell types, making them indispensable in the development of advanced therapies and vaccines. Their application spans from addressing rare genetic disorders to broad-based vaccine production, demonstrated most prominently by the success of viral vector platforms in COVID-19 vaccine development. The end-use scope includes pharmaceutical and biotechnology companies, research institutions, and contract manufacturing organizations that are deeply invested in harnessing these technologies. Market growth for viral vector manufacturing is driven by increasing approvals of gene therapies and rising incidences of genetic and chronic diseases, which heighten demand for innovative therapeutic solutions. Additionally, expanding research collaborations and escalating investments in the biotech sector fuel development, presenting lucrative opportunities. However, the market faces several challenges, such as high manufacturing costs, complex regulatory landscapes, and scalability issues, hindering full potential realization. Innovation continues to focus on enhancing vector productivity, reducing costs, and improving delivery efficiency, with research gravitating towards developing novel vector types and scalable production technologies. The market's nature is aggressive and rapidly changing, demanding agility and foresight from stakeholders to maintain competitive advantage. Opportunities for business growth lie in streamlining production mechanisms and addressing affordability issues, which could significantly expand consumer access to these groundbreaking therapies. Emphasizing partnerships and investment in cutting-edge research can also facilitate market entry and expansion. Organizations should focus on optimizing process efficiencies and scaling up production capabilities to tackle cost-related constraints and fortify market position.

KEY MARKET STATISTICS
Base Year [2023] USD 1.05 billion
Estimated Year [2024] USD 1.25 billion
Forecast Year [2030] USD 3.59 billion
CAGR (%) 19.11%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Viral Vector Manufacturing Market

The Viral Vector Manufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in prevalence of disease such as cancer, metabolic diseases, heart defects
    • Growth in development of gene therapy
    • Rise in registration of clinical trials for viral vector-mediated gene therapy
  • Market Restraints
    • Limited shelf-life of viral vector
  • Market Opportunities
    • High focus on yield optimization
    • Technology innovation in viral vector manufacturing
  • Market Challenges
    • Strict regulatory guidance for viral vector manufacturing

Porter's Five Forces: A Strategic Tool for Navigating the Viral Vector Manufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Viral Vector Manufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Viral Vector Manufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Viral Vector Manufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Viral Vector Manufacturing Market

A detailed market share analysis in the Viral Vector Manufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Viral Vector Manufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Viral Vector Manufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Viral Vector Manufacturing Market

A strategic analysis of the Viral Vector Manufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Viral Vector Manufacturing Market, highlighting leading vendors and their innovative profiles. These include ABL Inc., Beckman Coulter, Inc., Biovian Oy, Charles River Laboratories International, Inc., Cytiva, Finvector, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Genezen Laboratories, Inc., Lonza Group Ltd., Merck KGaA, Novartis AG, Sanofi SA, Spark Therapeutics, Inc. by F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., and uniQure N.V..

Market Segmentation & Coverage

This research report categorizes the Viral Vector Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Adeno-associated Viral Vectors, Adenoviral Vectors, Lentiviral Vectors, and Retroviral Vectors.
  • Based on Disease, market is studied across Cancer, Genetic Disorders, and Infectious Diseases.
  • Based on Application, market is studied across Gene Therapy and Vaccinology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in prevalence of disease such as cancer, metabolic diseases, heart defects
      • 5.1.1.2. Growth in development of gene therapy
      • 5.1.1.3. Rise in registration of clinical trials for viral vector-mediated gene therapy
    • 5.1.2. Restraints
      • 5.1.2.1. Limited shelf-life of viral vector
    • 5.1.3. Opportunities
      • 5.1.3.1. High focus on yield optimization
      • 5.1.3.2. Technology innovation in viral vector manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory guidance for viral vector manufacturing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Viral Vector Manufacturing Market, by Type

  • 6.1. Introduction
  • 6.2. Adeno-associated Viral Vectors
  • 6.3. Adenoviral Vectors
  • 6.4. Lentiviral Vectors
  • 6.5. Retroviral Vectors

7. Viral Vector Manufacturing Market, by Disease

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Genetic Disorders
  • 7.4. Infectious Diseases

8. Viral Vector Manufacturing Market, by Application

  • 8.1. Introduction
  • 8.2. Gene Therapy
  • 8.3. Vaccinology

9. Americas Viral Vector Manufacturing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Viral Vector Manufacturing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Viral Vector Manufacturing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ABL Inc.
  • 2. Beckman Coulter, Inc.
  • 3. Biovian Oy
  • 4. Charles River Laboratories International, Inc.
  • 5. Cytiva
  • 6. Finvector
  • 7. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • 8. Genezen Laboratories, Inc.
  • 9. Lonza Group Ltd.
  • 10. Merck KGaA
  • 11. Novartis AG
  • 12. Sanofi SA
  • 13. Spark Therapeutics, Inc. by F. Hoffmann-La Roche Ltd.
  • 14. Thermo Fisher Scientific Inc.
  • 15. uniQure N.V.

LIST OF FIGURES

  • FIGURE 1. VIRAL VECTOR MANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. VIRAL VECTOR MANUFACTURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. VIRAL VECTOR MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. VIRAL VECTOR MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VIRAL VECTOR MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VIRAL VECTOR MANUFACTURING MARKET DYNAMICS
  • TABLE 7. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ADENO-ASSOCIATED VIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ADENOVIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY LENTIVIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RETROVIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. VIRAL VECTOR MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. VIRAL VECTOR MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023